BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7947345)

  • 21. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants.
    de Lange P; Koper JW; Huizenga NA; Brinkmann AO; de Jong FH; Karl M; Chrousos GP; Lamberts SW
    Mol Endocrinol; 1997 Jul; 11(8):1156-64. PubMed ID: 9212062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
    Bamberger CM; Wald M; Bamberger AM; Schulte HM
    Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure.
    Sarlis NJ; Bayly SF; Szapary D; Simons SS
    J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):89-102. PubMed ID: 10369406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid-induced conformational changes of rat glucocorticoid receptor cause altered trypsin cleavage of the putative helix 6 in the ligand binding domain.
    Xu M; Modarress KJ; Meeker JE; Simons SS
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):85-100. PubMed ID: 10580842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vanadate increases glucocorticoid receptor-mediated gene expression: a novel mechanism for potentiation of a steroid receptor.
    Li Calzi S; Periyasamy S; Li DP; Sánchez ER
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):35-47. PubMed ID: 11867262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity.
    Keightley MC; Fuller PJ
    Mol Endocrinol; 1994 Apr; 8(4):431-9. PubMed ID: 8052264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helix 8 of the ligand binding domain of the glucocorticoid receptor (GR) is essential for ligand binding.
    Deng Q; Waxse B; Riquelme D; Zhang J; Aguilera G
    Mol Cell Endocrinol; 2015 Jun; 408():23-32. PubMed ID: 25676569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High level expression of wild type and variant mouse glucocorticoid receptors in Chinese hamster ovary cells.
    Hirst MA; Northrop JP; Danielsen M; Ringold GM
    Mol Endocrinol; 1990 Jan; 4(1):162-70. PubMed ID: 2157974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
    Whitacre DC; Karnas KJ; Miesfeld RL
    Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.
    Ashraf J; Thompson EB
    Mol Endocrinol; 1993 May; 7(5):631-42. PubMed ID: 8316249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
    Wu J; Li Y; Dietz J; Lala DS
    Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenylalanine-780 near the C-terminus of the mouse glucocorticoid receptor is important for ligand binding affinity and specificity.
    Chen D; Kohli K; Zhang S; Danielsen M; Stallcup MR
    Mol Endocrinol; 1994 Apr; 8(4):422-30. PubMed ID: 8052263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
    Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
    Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
    Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene.
    Mendonca BB; Leite MV; de Castro M; Kino T; Elias LL; Bachega TA; Arnhold IJ; Chrousos GP; Latronico AC
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1805-9. PubMed ID: 11932321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular identification and characterization of a and b forms of the glucocorticoid receptor.
    Yudt MR; Cidlowski JA
    Mol Endocrinol; 2001 Jul; 15(7):1093-103. PubMed ID: 11435610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evidence for the generation of a glucocorticoid receptor-heat shock protein-90 complex incapable of binding hormone by the calmodulin antagonist phenoxybenzamine.
    Ning YM; Sánchez ER
    Mol Endocrinol; 1996 Jan; 10(1):14-23. PubMed ID: 8838141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.